References:
Arnold, W. D., Kassar, D., & Kissel, J. T. (2015). Spinal muscular atrophy: diagnosis and management in a new therapeutic era. Muscle Nerve , 51, 157-167. doi: 10.1002/mus.24497
Chen, X. J., Levedakou, E. N., Millen, K. J., Wollmann, R. L., Soliven, B., & Popko, B. (2007). Proprioceptive sensory neuropathy in mice with a mutation in the cytoplasmic Dynein heavy chain 1 gene. J Neurosci , 27, 14515-14524. doi: 10.1523/JNEUROSCI.4338-07.2007
Harms, M. B., Allred, P., Gardner, R. J., Fernandes, F. J., Florence, J., Pestronk, A., Al-Lozi, M., & Baloh, R. H. (2010). Dominant spinal muscular atrophy with lower extremity predominance: linkage to 14q32.Neurology , 75, 539-546. doi: 10.1212/WNL.0b013e3181ec800c
Harms, M. B., Ori-McKenney, K. M., Scoto, M., Tuck, E. P., Bell, S., Ma, D., Masi, S., Allred, P., Al-Lozi, M., Reilly, M. M., Miller, L. J., Jani-Acsadi, A., Pestronk, A., Shy, M. E., Muntoni, F., Vallee, R. B., & Baloh, R. H. (2012). Mutations in the tail domain of DYNC1H1 cause dominant spinal muscular atrophy. Neurology , 78, 1714-1720. doi: 10.1212/WNL.0b013e3182556c05
Marzo, M. G., Griswold, J. M., Ruff, K. M., Buchmeier, R. E., Fees, C. P., & Markus, S. M. (2019). Molecular basis for dyneinopathies reveals insight into dynein regulation and dysfunction. Elife , 8. doi: 10.7554/eLife.47246
Pakhrin, P. S., Xie, Y., Hu, Z., Li, X., Liu, L., Huang, S., Wang, B., Yang, Z., Zhang, J., Liu, X., Xia, K., Tang, B., & Zhang, R. (2018). Genotype-phenotype correlation and frequency of distribution in a cohort of Chinese Charcot-Marie-Tooth patients associated with GDAP1 mutations.J Neurol , 265, 637-646. doi: 10.1007/s00415-018-8743-9
Pfister, K. K., Shah, P. R., Hummerich, H., Russ, A., Cotton, J., Annuar, A. A., King, S. M., & Fisher, E. M. (2006). Genetic analysis of the cytoplasmic dynein subunit families. PLoS Genet , 2, e1. doi: 10.1371/journal.pgen.0020001
Poirier, K., Lebrun, N., Broix, L., Tian, G., Saillour, Y., Boscheron, C., Parrini, E., Valence, S., Pierre, B. S., Oger, M., Lacombe, D., Geneviève, D., Fontana, E., Darra, F., Cances, C., Barth, M., Bonneau, D., Bernadina, B. D., N’Guyen, S.,… Chelly, J. (2013). Mutations in TUBG1, DYNC1H1, KIF5C and KIF2A cause malformations of cortical development and microcephaly. Nat Genet , 45, 639-647. doi: 10.1038/ng.2613
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., Voelkerding, K., & Rehm, H. L. (2015). Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine , 17, 405-423. doi: 10.1038/gim.2015.30
Rossor, A. M., Kalmar, B., Greensmith, L., & Reilly, M. M. (2012). The distal hereditary motor neuropathies. J Neurol Neurosurg Psychiatry , 83, 6-14. doi: 10.1136/jnnp-2011-300952
Schiavo, G., Greensmith, L., Hafezparast, M., & Fisher, E. M. (2013). Cytoplasmic dynein heavy chain: the servant of many masters.Trends Neurosci , 36, 641-651. doi: 10.1016/j.tins.2013.08.001
Tsurusaki, Y., Saitoh, S., Tomizawa, K., Sudo, A., Asahina, N., Shiraishi, H., Ito, J., Tanaka, H., Doi, H., Saitsu, H., Miyake, N., & Matsumoto, N. (2012). A DYNC1H1 mutation causes a dominant spinal muscular atrophy with lower extremity predominance. Neurogenetics , 13, 327-332. doi: 10.1007/s10048-012-0337-6
Weedon, M. N., Hastings, R., Caswell, R., Xie, W., Paszkiewicz, K., Antoniadi, T., Williams, M., King, C., Greenhalgh, L., Newbury-Ecob, R., & Ellard, S. (2011). Exome sequencing identifies a DYNC1H1 mutation in a large pedigree with dominant axonal Charcot-Marie-Tooth disease. Am J Hum Genet , 89, 308-312. doi: 10.1016/j.ajhg.2011.07.002